Wave Life Sciences Ltd.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd.

Overview
Date Founded

2012

Headquarters

7 Straits View,Marina One East Tower,No. 12-00,Singapore, Central Singapore 018936

Type of Company

Public

Employees (Worldwide)

220

Industries

Biotechnology

Company Description

Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Contact Data
Trying to get in touch with decision makers at Wave Life Sciences Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer & Director

Chief Financial Officer

General Counsel

Chief Technology Officer

Chief Human Resources Officer

Chief Medical Officer, Head of Therapeutics Discovery & Development

Senior Vice President, Corporate Development & Head of Emerging Areas

Senior Vice President, Corporate Affairs & Patient Advocacy

Senior Vice President, Therapeutics Discovery

Executive Officer

Board of Directors

President & Chief Executive Officer at Pacific Biosciences of California, Inc.

Founder at LifeMine Therapeutics, Inc.

Executive Officer at Mitsubishi Estate Logistics REIT Investment Corp.

Chief Executive Officer at Adaptimmune Therapeutics PLC

President, Chief Executive Officer & Director at Wave Life Sciences Ltd.

Quality Assurance Specialist at Amgen, Inc.

Former Executive Chairman at Blackthorn Therapeutics, Inc.

Former Chief Financial Officer at DuPont Titanium Technologies, Inc.

Paths to Wave Life Sciences Ltd.
Potential Connections via
Relationship Science
You
Wave Life Sciences Ltd.
Owners & Shareholders
Details Hidden

RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization.

Details Hidden

Ikarian Capital LLC is a private company headquartered in Dallas, TX, with a presence in the United States and the Cayman Islands. The firm provides investment advice. It was founded by Neil Tristan Shahrestani.

Details Hidden

ARIAD Asset Management GmbH is a German private company located in Hamburg that provides investment advice. It was founded in 2002 by Carsten Lund and Klaus Walczak. Carsten Lund and Klaus Walczak are the current co-CEOs of the firm.

Recent Transactions
Details Hidden

Wave Life Sciences Ltd. issued USD Ordinary Shares

Details Hidden

Wave Life Sciences Ltd. issued USD Ordinary Shares

Details Hidden

Wave Life Sciences Ltd. issued USD Common Stock

Transaction Advisors
Underwriter

Advised onWave Life Sciences Ltd. issued USD Ordinary Shares

Escrow Agent

Advised onWave Life Sciences Ltd. issued USD Ordinary Shares

Underwriter

Advised onWave Life Sciences Ltd. issued USD Ordinary Shares

Professional

Advised onWave Life Sciences Ltd. issued USD Ordinary Shares

Associate

Advised onWave Life Sciences Ltd. issued USD Ordinary Shares

Underwriter

Advised onWave Life Sciences Ltd. issued USD Ordinary Shares

Clients

Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Takeda's ethical drugs are marketed in around 100 countries worldwide.

Key Stats and Financials As of 2020
Market Capitalization
$156M
Total Enterprise Value
$161M
Earnings Per Share
$-3.82
Revenue
$20.1M
EBITDAMargin
-714.22%
Debt TEV
0.18x
TEVNet Income
-1.08x
Enterprise Value / Sales
8.04x
Total Debt
$29.3M
Total Equity
$90.7M
EBITDA
$-143M
Net Profit
$-150M
Three Year Compounded Annual Growth Rate Of Revenue
75.61%
Investors
Details Hidden

RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization.

Details Hidden

Cormorant Asset Management invests in companies located in the US. The firm targets companies in sectors such as life-science and biotech. They provide financing for mezzanine and early stage capital requirements.

Suppliers
Dyne Therapeutics, Inc. Biotechnology | Waltham, Massachusetts

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.

Competitors
Alnylam Pharmaceuticals, Inc. Pharmaceuticals - Cambridge, Massachusetts

Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

Vertex Pharmaceuticals, Inc. Pharmaceuticals - Boston, MA

Vertex Pharmaceuticals, Inc. is a global biotechnology company. It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

SAGE Therapeutics, Inc. Pharmaceuticals - Cambridge, Massachusetts

SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Wave Life Sciences Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Wave Life Sciences Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Wave Life Sciences Ltd..